Day

August 4, 2021
PARAMUS, UNITED STATES, August 4, 2021 /EINPresswire.com/ — WG Critical Care, LLC will be introducing the first and only FDA-approved, Ready-To-Use (RTU) Midazolam in 0.9% Sodium Chloride Injection CIV in single-dose bags. Midazolam is currently controlled in schedule IV of the Controlled Substance Act. The launch of Ready-To-Use Midazolam in 0.9% Sodium Chloride Injection CIV...
Read More
© 2022 WG Critical Care, LLC | A PharmaSphere Company | 120 Rte 17 N, Paramus, NJ 07652
Due to the unprecedented nature of the COVID-19 pandemic, anyone reporting an Adverse Event and/or a Product Complaint via phone, should you receive a network busy signal (ie: if all lines busy/engaged) please continue to try your call throughout the day. Alternatively, you may email your Adverse Event to drugsafety@propharmagroup.com OR Product Complaint to productcomplaint@propharmagroup.com, OR medical information request to MedInfo@propharmagroup.com.